News
A new mHealth platform launched by the Joslin Diabetes Center and Glooko targets diabetics who are susceptible to glycemia, a condition that could result in hospitalization or even death if untreated.
According to the FDA's final guidance, the key to determining whether the FDA will regulate your mobile app is the concept of intended use.
From digital mapping to point-of-care diagnostics to social media, the healthcare world is using technology to identify and contain a deadly epidemic.